Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Moses

Showing results (11-20 of 202) with videos related to

Pageof 21
Sort By:
Annals of the New York Academy of Sciences|March 30, 1978
Drug treatment of mild hypertension: adverse consequencesC Moses
Federation Proceedings|March 19, 2010
An experimental study of intramuscular pressure measurementsC MOSES
Clinical Therapeutics|January 1, 1988
Clinical therapeutics resurgentC Moses
Diabetes Technology & Therapeutics|October 1, 2010
Comment on "The broken pen penalty" (Lakshmanadoss et al.)Alan C Moses
Journal of Periodontology|November 1, 2007
Commentary: will it take Harry Potter to solve diabetes? Divining the future of diabetes careAlan C Moses
Endocrine Development|May 10, 2005
Insulin resistance and type 2 diabetes mellitus: is there a therapeutic role for IGF-1?Alan C Moses
Endocrinology|June 1, 1990
Somatostatin inhibits deoxyribonucleic acid synthesis induced by both thyrotropin and insulin-like growth factor-I in FRTL5 cellsS Tsuzaki, A C Moses
Diabetes Technology & Therapeutics|May 18, 2010
Response to Swinnen et alAlan C Moses, Christoph Koenen
Diabetes Care|September 1, 1984
Hypoglycemia associated with trimethoprim/sulfamethoxazole therapyL Poretsky, A C Moses
Biochemical and Biophysical Research Communications|February 28, 1989
The A1 adenosine receptor antagonist 1,3, dipropyl-8-cyclopentylxanthine (DPCPX) displays adenosine agonist properties in the FRTL5 thyroid cell lineA G Frauman, A C Moses
Pageof 21

Showing results (11-20 of 202) with videos related to

Sort By:
Pageof 21
Annals of the New York Academy of Sciences|March 30, 1978
Drug treatment of mild hypertension: adverse consequencesC Moses
Federation Proceedings|March 19, 2010
An experimental study of intramuscular pressure measurementsC MOSES
Clinical Therapeutics|January 1, 1988
Clinical therapeutics resurgentC Moses
Diabetes Technology & Therapeutics|October 1, 2010
Comment on "The broken pen penalty" (Lakshmanadoss et al.)Alan C Moses
Journal of Periodontology|November 1, 2007
Commentary: will it take Harry Potter to solve diabetes? Divining the future of diabetes careAlan C Moses
Endocrine Development|May 10, 2005
Insulin resistance and type 2 diabetes mellitus: is there a therapeutic role for IGF-1?Alan C Moses
Endocrinology|June 1, 1990
Somatostatin inhibits deoxyribonucleic acid synthesis induced by both thyrotropin and insulin-like growth factor-I in FRTL5 cellsS Tsuzaki, A C Moses
Diabetes Technology & Therapeutics|May 18, 2010
Response to Swinnen et alAlan C Moses, Christoph Koenen
Diabetes Care|September 1, 1984
Hypoglycemia associated with trimethoprim/sulfamethoxazole therapyL Poretsky, A C Moses
Biochemical and Biophysical Research Communications|February 28, 1989
The A1 adenosine receptor antagonist 1,3, dipropyl-8-cyclopentylxanthine (DPCPX) displays adenosine agonist properties in the FRTL5 thyroid cell lineA G Frauman, A C Moses
Pageof 21